Potential of Advexin®®: a p53 gene-replacement therapy in Li––Fraumeni syndrome

Author: Nemunaitis Jackie M   Nemunaitis John  

Publisher: Future Medicine

ISSN: 1479-6694

Source: Future Oncology, Vol.4, Iss.6, 2008-12, pp. : 759-768

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract